- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-3-mer
- Ligands
- 21 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 9 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA.3: 5 residues within 4Å:- Chain A: E.88, V.90, N.245, N.257, S.259
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.8: 2 residues within 4Å:- Chain A: N.376, R.480
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.9: 6 residues within 4Å:- Chain A: H.377, V.386, N.400, T.402
- Chain C: S.103, W.104
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.14: 5 residues within 4Å:- Chain E: E.88, V.90, N.245, N.257, S.259
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.19: 2 residues within 4Å:- Chain E: N.376, R.480
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.20: 8 residues within 4Å:- Chain E: H.377, V.386, N.400, T.402
- Chain G: Y.102, S.103, W.104
- Ligands: NAG.50
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.25: 5 residues within 4Å:- Chain I: E.88, V.90, N.245, N.257, S.259
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.30: 2 residues within 4Å:- Chain I: N.376, R.480
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.31: 8 residues within 4Å:- Chain I: H.377, V.386, N.400, T.402
- Chain K: Y.102, S.103, W.104
- Ligands: NAG.61
No protein-ligand interaction detected (PLIP)- 3 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN.4: 9 residues within 4Å:- Chain A: V.270, L.277, N.278, N.391, G.393, R.455, S.457, S.458
- Ligands: NAG-NAG.11
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:G.393
NAG-NAG-BMA-MAN.15: 8 residues within 4Å:- Chain E: V.270, L.277, N.278, N.391, G.393, S.457, S.458
- Ligands: NAG-NAG.22
2 PLIP interactions:2 interactions with chain E- Hydrogen bonds: E:S.225, E:G.393
NAG-NAG-BMA-MAN.26: 9 residues within 4Å:- Chain I: V.270, L.277, N.278, N.391, G.393, R.455, S.457, S.458
- Ligands: NAG-NAG.33
1 PLIP interactions:1 interactions with chain I- Hydrogen bonds: I:G.393
- 33 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.34: 1 residues within 4Å:- Chain A: N.93
Ligand excluded by PLIPNAG.35: 3 residues within 4Å:- Chain A: N.169, V.170, I.174
Ligand excluded by PLIPNAG.36: 4 residues within 4Å:- Chain A: N.317, T.319, D.336, I.338
Ligand excluded by PLIPNAG.37: 4 residues within 4Å:- Chain A: N.354, R.413, D.416, P.418
Ligand excluded by PLIPNAG.38: 2 residues within 4Å:- Chain A: P.369, N.370
Ligand excluded by PLIPNAG.39: 3 residues within 4Å:- Chain A: P.403, N.406, Y.417
Ligand excluded by PLIPNAG.40: 2 residues within 4Å:- Chain A: T.372, N.410
Ligand excluded by PLIPNAG.41: 3 residues within 4Å:- Chain B: N.100, S.102, W.103
Ligand excluded by PLIPNAG.42: 1 residues within 4Å:- Chain B: N.105
Ligand excluded by PLIPNAG.43: 3 residues within 4Å:- Chain B: E.110, D.113, N.114
Ligand excluded by PLIPNAG.44: 3 residues within 4Å:- Chain B: K.122, D.125, N.126
Ligand excluded by PLIPNAG.45: 1 residues within 4Å:- Chain E: N.93
Ligand excluded by PLIPNAG.46: 3 residues within 4Å:- Chain E: N.169, V.170, I.174
Ligand excluded by PLIPNAG.47: 4 residues within 4Å:- Chain E: N.317, T.319, D.336, I.338
Ligand excluded by PLIPNAG.48: 4 residues within 4Å:- Chain E: N.354, R.413, D.416, P.418
Ligand excluded by PLIPNAG.49: 2 residues within 4Å:- Chain E: P.369, N.370
Ligand excluded by PLIPNAG.50: 4 residues within 4Å:- Chain E: P.403, N.406, Y.417
- Ligands: NAG-NAG-BMA.20
Ligand excluded by PLIPNAG.51: 2 residues within 4Å:- Chain E: T.372, N.410
Ligand excluded by PLIPNAG.52: 2 residues within 4Å:- Chain F: N.100, S.102
Ligand excluded by PLIPNAG.53: 1 residues within 4Å:- Chain F: N.105
Ligand excluded by PLIPNAG.54: 3 residues within 4Å:- Chain F: E.110, D.113, N.114
Ligand excluded by PLIPNAG.55: 3 residues within 4Å:- Chain F: K.122, D.125, N.126
Ligand excluded by PLIPNAG.56: 1 residues within 4Å:- Chain I: N.93
Ligand excluded by PLIPNAG.57: 3 residues within 4Å:- Chain I: N.169, V.170, I.174
Ligand excluded by PLIPNAG.58: 4 residues within 4Å:- Chain I: N.317, T.319, D.336, I.338
Ligand excluded by PLIPNAG.59: 4 residues within 4Å:- Chain I: N.354, R.413, D.416, P.418
Ligand excluded by PLIPNAG.60: 2 residues within 4Å:- Chain I: P.369, N.370
Ligand excluded by PLIPNAG.61: 4 residues within 4Å:- Chain I: P.403, N.406, Y.417
- Ligands: NAG-NAG-BMA.31
Ligand excluded by PLIPNAG.62: 2 residues within 4Å:- Chain I: T.372, N.410
Ligand excluded by PLIPNAG.63: 3 residues within 4Å:- Chain J: N.100, S.102, W.103
Ligand excluded by PLIPNAG.64: 1 residues within 4Å:- Chain J: N.105
Ligand excluded by PLIPNAG.65: 3 residues within 4Å:- Chain J: E.110, D.113, N.114
Ligand excluded by PLIPNAG.66: 3 residues within 4Å:- Chain J: K.122, D.125, N.126
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Ozorowski, G. et al., Open and closed structures reveal allostery and pliability in the HIV-1 envelope spike. Nature (2017)
- Release Date
- 2017-07-12
- Peptides
- Envelope glycoprotein gp160: AEI
Envelope glycoprotein gp160: BFJ
b12 Fab heavy chain: CGK
b12 Fab light chain: DHL - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
GE
DI
EB
AF
BJ
CC
HG
FK
ID
LH
JL
K
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-3-mer
- Ligands
- 21 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 9 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 33 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Ozorowski, G. et al., Open and closed structures reveal allostery and pliability in the HIV-1 envelope spike. Nature (2017)
- Release Date
- 2017-07-12
- Peptides
- Envelope glycoprotein gp160: AEI
Envelope glycoprotein gp160: BFJ
b12 Fab heavy chain: CGK
b12 Fab light chain: DHL - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
GE
DI
EB
AF
BJ
CC
HG
FK
ID
LH
JL
K